Protein synthesis by platelets
Cardiovascular disease in patients with hemophilia
Endothelial progenitor cells – hype or hope?
ABO genotype and risk of thrombotic events and hemorrhagic stroke
Assessing the contribution of fibrinogen in predicting risk of death in men with peripheral arterial disease
Activated factor XII type A predicts long-term mortality in patients admitted with chest pain1
Tissue factor and heart inflammation
Active site inhibited factor VIIa attenuates myocardial ischemia/reperfusion injury in mice
Evaluation of the safety and pharmacokinetics of a fast-acting recombinant FVIIa analogue, NN1731, in healthy male subjects
Inherited thrombophilias and unexplained pregnancy loss
Pregnancy-associated changes in the hemostatic system in wild-type and factor V Leiden mice
Primary immune thrombocytopenia
Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura
A role for TRPV1 in agonist-evoked activation of human platelets
Molecular basis of platelet activation by an αIIbβ3-CHAMPS peptide
ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans
Recommendations for nomenclature on fibrinogen and fibrin
Scientific and standardization committee communications
Platelet inorganic polyphosphate decreases in patients with delta storage pool disease
Platelet hyperreactivity and dual antiplatelet therapy
Polymorphisms in chromosome 9 and risk of ischemic stroke in two European white populations, and a meta-analysis
Mosaicism in men in hemophilia
Insulin inhibition of platelet-endothelial interaction is mediated by insulin effects on endothelial cells without direct effects on platelets
Insulin inhibition of platelet-endothelial interaction is mediated by insulin effects on endothelial cells without direct effects on platelets
Join ISTH